Neuraxis, INC — Investor Relations & Filings

Neuraxis, Inc. is a medical technology company that develops and commercializes neuromodulation therapies for chronic and debilitating conditions, particularly disorders of gut-brain interactions (DGBIs). The company's core technology is Percutaneous Electrical Nerve Field Stimulation (PENFS). Its flagship product, IB-Stim, is an FDA-cleared, non-surgical, drug-free device for treating functional abdominal pain associated with Irritable Bowel Syndrome (IBS) and functional dyspepsia. While initially focused on the pediatric and adolescent population, Neuraxis is expanding its therapies to adult patients. The company's portfolio also includes RED, an FDA-cleared device for the testing and evaluation of patients with chronic constipation.